Anzeige
Mehr »
Login
Montag, 12.04.2021 Börsentäglich über 12.000 News von 660 internationalen Medien
InnoCan Pharma: Was steckt dahinter? Strong Buy!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 885823 ISIN: US3755581036 Ticker-Symbol: GIS 
Tradegate
12.04.21
21:31 Uhr
54,39 Euro
-0,31
-0,57 %
1-Jahres-Chart
GILEAD SCIENCES INC Chart 1 Jahr
5-Tage-Chart
GILEAD SCIENCES INC 5-Tage-Chart
RealtimeGeldBriefZeit
54,1054,4522:07
54,2354,3622:00

Aktuelle News zur GILEAD SCIENCES Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
19:08India axes exports of Gilead Sciences' remdesivir, plots boost to local production as COVID cases mount: reports7
FrEVEREST MED-B (01952): VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE ON LICENSING PARTNER GILEAD SCIENCES, INC. RECEIVING FULL US FDA APPROVAL OF TRODELVY FOR THE TREATMENT OF PREVIOUSLY TREATED UNRESECTABLE ...39
GILEAD SCIENCES Aktie jetzt für 0€ handeln
DoGilead-Galapagos extends lock-up period for collaboration38
DoGalapagos NV: Extension of lock-up period in Gilead-Galapagos collaboration agreement454Mechelen, Belgium; 08 April 2021; 22.01 CET; Galapagos (Euronext & Nasdaq; GLPG) announced today that Gilead and Galapagos signed an amendment to the share subscription agreement closed in 2019...
► Artikel lesen
DoGilead snags full Trodelvy breast cancer nod, but it needs more to make the $21B Immunomedics buy worthwhile24
DoA Look Into Gilead Sciences Price Over Earnings37
DoGilead (GILD) Gets Full Approval for Breast Cancer Drug Trodelvy13
DoThe Daily Biotech Pulse: Immutep Extends Run, FDA Nod For Gilead, Merck, Bristol-Myers Squibb Release Late-Stage Cancer Immunotherapy Data7
DoGilead wins full FDA approval for Trodelvy in triple-negative breast cancer12
DoIs Gilead Sciences Stock a Buy?56
DoGilead's Trodelvy Wins FDA Regular Approval For Triple-Negative Breast Cancer9
DoEyeing standard of care status in 3rd-line TNBC, Gilead nails down full OK for Trodelvy with a slightly broader label4
DoFDA Approves Gilead's Trodelvy To Treat Metastatic Triple-Negative Breast Cancer398FOSTER CITY (dpa-AFX) - Gilead Sciences Inc. (GILD) said that the U.S. Food and Drug Administration has granted full approval to Trodelvy or sacituzumab govitecan-hziy for adult patients with...
► Artikel lesen
DiDespite remdesivir approval and 2 big buyouts, Gilead CEO Dan O'Day sees pay fall 35% from 201978
05.04.CEO Dan O'Day, tasked with boosting Gilead's oncology presence, scores $19M for a year focused on COVID36
05.04.Better Buy for 2021: Pfizer or Gilead?131
02.04.Gilead expands AbCellera antibody discovery pact to access rival to Regeneron's mouse platform91
01.04.Gilead submits sBLA for Tecartus for acute lymphoblastic leukemia28
01.04.Gilead has sole rights to COVID-19 blockbuster Veklury, GAO concludes77
01.04.United Therapeutics bags a new OK on Tyvaso, with blockbuster expectations; Gilead goes back to AbCellera's well with a set of fresh targets41
Seite:  Weiter >>
804 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
89,27,102